No Data
On January 8, LIVZON PHARMA (01513) invested 10 million yuan to repurchase 0.2747 million shares of A-shares.
LIVZON PHARMA (01513) announced that on January 8, 2025, the company will spend 10 million yuan to repurchase 2...
LIVZON PHARMA (01513) provides a guarantee of 0.2 billion yuan to its subsidiary Livzon Pharmaceutical Group Inc. Livzon Pharmaceutical Factory.
LIVZON PHARMA (01513) announced that in December 2024, the company will collaborate with China Construction Bank Corporation in Zhuhai...
Pharmaceutical stocks have become a transitional theme at present, and the performance line may be further valued by the market.
Track the entire lifecycle of the main sector.
How is the quality and supply of Pharmaceuticals guaranteed? The National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals.
On December 26, 2024, the National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals, inviting representatives from the National Medical Products Administration, selected Pharmaceutical enterprises, and research Institutions to communicate and exchange views on recent societal concerns regarding quality assurance of centrally procured Pharmaceuticals and innovative development in the Industry, and to listen to opinions and suggestions.
Announcement highlights | CHINA POWER's electricity sales volume increased by nearly 30% year-on-year in the first 11 months; WUXI APPTEC plans to sell its WuXi ATU Business in the USA and United Kingdom.
WUXI APPTEC plans to sell its WuXi ATU Business in the USA and United Kingdom; GF SEC's proprietary business can participate in carbon emission trading at legal trading venues within the territory.
Livzon Pharmaceutical Group Inc. (000513.SZ): Spent 5.4997 million yuan to repurchase 0.1457 million A-shares.
On December 25, Glonghui reported that Livzon Pharmaceutical Group Inc. (000513.SZ) announced the repurchase of 0.1457 million shares of its A-shares for the first time through centralized bidding on December 25, 2024, accounting for 0.02% of the company's total share capital. The highest purchase price was 37.97 yuan per share, and the lowest price was 37.50 yuan per share, with a total amount of funds used being 5.4997 million yuan (excluding transaction fees).
The Market Doesn't Like What It Sees From Livzon Pharmaceutical Group Inc.'s (SZSE:000513) Earnings Yet
